In a blow to Johnson & Johnson, the company was ordered last Friday to pay $70 million to a male Tennessee teenager who claimed its Risperdal antipsychotic pill caused him to grow enlarged breasts.

The Arkansas Supreme Court today overturned a $1.2 billion jury verdict against Johnson & Johnson in a case involving the marketing of its Risperdal anti-psychotic medication. The Arkansas Supreme ...

PHILADELPHIA — A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys ...

J&J to Pay $2.2B Settlement to End Risperdal Probes New Brunswick, N.J.-based Johnson & Johnson has agreed to pay up to $2.2 billion to settle U.S. investigations and lawsuits regarding its marketing ...

Johnson & Johnson last fall suffered a major legal defeat in its defense of antipsychotic Risperdal, but that loss was short-lived. After a jury ordered J&J to pay a plaintiff a staggering $8 billion, ...

The jury determined the award should go to a single plaintiff. A Pennsylvania jury ordered Johnson & Johnson and its drugmakers Janssen Pharmaceuticals to pay $8 billion in damages in a lawsuit over ...

Johnson & Johnson (NYSE:JNJ) says it has settled most of the lawsuits in the anti-psychotic drug Risperdal cases and has recorded $800 million in expenses in connection with the agreement. The medical ...

A judge on Friday took an axe to a legal award against Johnson & Johnson — chopping the settlement from $8 billion to $6.8 million — in the case of a man who said the company failed to warn consumers ...

A Philadelphia jury has ordered medical company Johnson & Johnson to pay $8 billion in punitive damages in the case of a man who said he developed breasts after taking the company's anti-psychotic ...

In a setback to Johnson & Johnson, a Philadelphia jury decided the health care giant must pay $2.5 million in damages for failing to warn that its Risperdal antipsychotic could cause gynecomastia, ...

NEW YORK (Reuters) - A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal.